Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease

Published:2019-06-18 Issue:1 Volume:26 Page:43-55
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Ferrer-Picón Elena¹,Dotti Isabella¹,Corraliza Ana M¹,Mayorgas Aida¹,Esteller Miriam¹,Perales José Carlos²,Ricart Elena¹,Masamunt Maria C¹,Carrasco Anna³^ORCID,Tristán Eva³,Esteve Maria³,Salas Azucena¹

Affiliation:

1. Department of Gastroenterology, IDIBAPS, Hospital Clínic, CIBERehd, Barcelona, Spain

2. Department of Physiological Sciences, Faculty of Medicine, University of Barcelona, L’Hospitalet del Llobregat, Barcelona, Spain

3. Department of Gastroenterology, Hospital Universitari Mútua Terrassa, CIBERehd, Barcelona, Spain

Abstract

Ferrer-Picón et al. show that in active IBD patients, tumor necrosis factor alpha affects the response of the intestinal epithelium to bacteria-derived butyrate. This observation raises questions about the beneficial effects of butyrate supplementation during active inflammation.

Funder

Ministerio de Economía y Competitividad, Spain,

Leona and Harry Helmsley Charitable Trust

European Social Fund

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/article-pdf/26/1/43/31495466/izz119.pdf

Reference42 articles.